Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.

The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.

Unearth how modern software development in clinical research technology will shape the industry's future.

Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.

Explore how digital health technologies offer a data-driven solution to cytokine release syndrome (CRS) monitoring, reducing inpatient care requirements while ensuring patient safety.

Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.

From balancing treatment ratios and managing eligibility to accommodating site-specific readiness and protocol amendments, a well-designed IRT system enables seamless transitions.

Unearth the ways electronic clinical outcome assessment technology is revolutionizing data collection, improving patient experiences, and enhancing trial outcomes.

A clear guide to U.S. coverage, regulation, and reimbursement: who decides care, how products gain access, and how policy and financing shape cost, value, and patient access.

Updated GCP expectations reshape sponsor–site collaboration. Clear guidance on systems, data governance, and monitoring reduces risk, strengthens oversight, and supports compliance with ICH E6(R3).

Explore 2026 policy trends across drug‑pricing actions, affordability pressures, value‑driven evaluation, shifts in global innovation, and new AI regulatory applications.

Are you managing site payments with spreadsheets and manual processes? Discover how automation can reduce administrative burden, improve site relationships, and accelerate clinical trial operations.

The effort to build a single home for sites to access their trial systems has demonstrated that the industry is ready to forego competitive discourse to deliver benefits to sites and patients.

Seasoned clinical research expert and advocate of data ethics Angela Radcliffe discusses how the industry can enhance the lives of both patients and clinical trial sites.